• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在每周三次血液透析患者强化容量管理期间的容量指标和左心室质量。

Volume indicators and left ventricular mass during aggressive volume management in patients on thrice-weekly hemodialysis.

机构信息

Division of Nephrology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.

出版信息

Nephron Clin Pract. 2009;113(4):c270-80. doi: 10.1159/000235252. Epub 2009 Aug 15.

DOI:10.1159/000235252
PMID:19684412
Abstract

OBJECTIVE

We examined the relationship between various volume indicators, i.e. multifrequency bioelectric impedance analysis (BIA), predialysis serum N-terminus-pro-brain natriuretic peptide (NT[-]pro[-]BNP) levels, and inferior vena cava diameter, and left ventricular mass index (LVMI) at baseline and with rigorous volume management on thrice-weekly hemodialysis.

METHODS

Twenty-two patients on chronic thrice-weekly hemodialysis were followed for 52 weeks. Left ventricular hypertrophy was present in 100% of the cohort at baseline.

RESULTS

There were no significant correlations among volume indicators except for a correlation between extracellular-volume-to-body-mass ratio and collapsibility index (r = 0.476; p = 0.039) at 6 months. There were no correlations between blood pressure and volume indicators. Baseline (but not follow-up) collapsibility index correlated with LVMI (r = 0.506; p = 0.038). In 'lag-time' analyses, there were no correlations between volume indicators at baseline or 6 months and LVMI at subsequent time points. LVMI decreased from 243.6 +/- 83.3 g/m(2) at baseline to 210.6 +/- 62.9 g/m(2) at 6 months (p = 0.104) and further to 203.2 +/- 49.0 g/m(2) at 12 months (p = 0.035).

CONCLUSIONS

(1) Left ventricular hypertrophy was prevalent in hemodialysis patients; (2) BIA, inferior vena cava ultrasound and serum NT-pro-BNP levels yield discordant results for fluid volumes; (3) regression of LVMI could occur with rigorous fluid management, even with thrice-weekly dialysis.

摘要

目的

我们研究了各种容量指标(即多频生物电阻抗分析(BIA)、透析前血清 N 末端前脑利钠肽(NT-pro-BNP)水平和下腔静脉直径)与左心室质量指数(LVMI)在基线时以及在每周三次血液透析时进行严格容量管理时的关系。

方法

22 名接受慢性每周三次血液透析的患者进行了 52 周的随访。基线时,该队列中 100%的患者存在左心室肥厚。

结果

除了 6 个月时细胞外液与体重比与塌陷指数之间存在相关性(r = 0.476;p = 0.039)外,容量指标之间无显著相关性。血压与容量指标之间无相关性。基线(而非随访)时的塌陷指数与 LVMI 相关(r = 0.506;p = 0.038)。在“滞后时间”分析中,基线或 6 个月时的容量指标与随后时间点的 LVMI 之间无相关性。LVMI 从基线时的 243.6 ± 83.3 g/m2降至 6 个月时的 210.6 ± 62.9 g/m2(p = 0.104),进一步降至 12 个月时的 203.2 ± 49.0 g/m2(p = 0.035)。

结论

(1)血液透析患者中普遍存在左心室肥厚;(2)BIA、下腔静脉超声和血清 NT-pro-BNP 水平对容量的检测结果不一致;(3)即使每周透析 3 次,通过严格的液体管理,LVMI 也可能会得到逆转。

相似文献

1
Volume indicators and left ventricular mass during aggressive volume management in patients on thrice-weekly hemodialysis.在每周三次血液透析患者强化容量管理期间的容量指标和左心室质量。
Nephron Clin Pract. 2009;113(4):c270-80. doi: 10.1159/000235252. Epub 2009 Aug 15.
2
Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.稳定血液透析患者N端前脑钠肽水平变化与左心室质量指数变化之间的关联
Nephron Clin Pract. 2008;110(2):c93-100. doi: 10.1159/000157622. Epub 2008 Sep 25.
3
Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.每日透析可降低血浆中脑钠肽(BNP)的水平,脑钠肽是左心室功能障碍的生物标志物。
Hemodial Int. 2006 Oct;10(4):394-8. doi: 10.1111/j.1542-4758.2006.00136.x.
4
The long-term behavior and predictors of left ventricular hypertrophy in hemodialysis patients.血液透析患者左心室肥厚的长期行为及预测因素
Am J Kidney Dis. 2006 Mar;47(3):485-92. doi: 10.1053/j.ajkd.2005.12.029.
5
Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.N末端B型利钠肽原(NT-proBNP)对慢性肾脏病5期血液透析患者左心室功能障碍的诊断价值
Nephrol Dial Transplant. 2008 Apr;23(4):1370-7. doi: 10.1093/ndt/gfm700. Epub 2007 Dec 18.
6
Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.血液透析患者中高血容量、左心室肥厚与成纤维细胞生长因子23之间的相关性。
Ren Fail. 2015 Jul;37(6):951-6. doi: 10.3109/0886022X.2015.1052945. Epub 2015 Jun 1.
7
Long-term evolution and changing associations of left ventricular hypertrophy after starting hemodialysis.开始血液透析后左心室肥厚的长期演变及变化的相关性
Nephron Clin Pract. 2008;110(2):c126-32. doi: 10.1159/000163845. Epub 2008 Oct 16.
8
Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.慢性腹膜透析患者血清生物标志物对左心室异常的诊断潜力
Nephrol Dial Transplant. 2009 Jun;24(6):1962-9. doi: 10.1093/ndt/gfp067. Epub 2009 Feb 23.
9
N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.N末端前B型利钠肽和B型利钠肽用于识别门诊慢性肾病患者的冠状动脉疾病和左心室肥厚。
Am J Cardiol. 2006 May 15;97(10):1530-4. doi: 10.1016/j.amjcard.2005.11.090. Epub 2006 Mar 31.
10
The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.血液透析和持续性非卧床腹膜透析患者中内脂素水平与炎性细胞因子及左心室肥厚的关系
Ren Fail. 2008;30(6):617-23. doi: 10.1080/08860220802134573.

引用本文的文献

1
Is N-terminal pro-brain natriuretic peptide a reliable marker for body fluid status in children with chronic kidney disease?N端前脑钠肽是否是慢性肾病患儿体液状态的可靠标志物?
Arch Med Sci. 2019 Jun 3;16(4):802-810. doi: 10.5114/aoms.2019.85460. eCollection 2020.
2
Fluid and hemodynamic management in hemodialysis patients: challenges and opportunities.血液透析患者的液体与血流动力学管理:挑战与机遇
J Bras Nefrol. 2019 Oct-Dec;41(4):550-559. doi: 10.1590/2175-8239-JBN-2019-0135.
3
The interaction between N-terminal pro-brain natriuretic peptide and fluid status in adverse clinical outcomes of late stages of chronic kidney disease.
脑钠肽前体 N 端片段与液体状态在慢性肾脏病晚期不良临床结局中的相互作用。
PLoS One. 2018 Aug 22;13(8):e0202733. doi: 10.1371/journal.pone.0202733. eCollection 2018.
4
Usefulness of US imaging in overhydrated nephropathic patients.超声成像在水负荷过重的肾病患者中的应用价值。
J Ultrasound. 2014 Dec 13;19(1):7-13. doi: 10.1007/s40477-014-0152-z. eCollection 2016 Mar.
5
Interdialytic weight gain in oligoanuric children and adolescents on chronic hemodialysis.慢性血液透析的少尿性儿童及青少年透析间期体重增加情况
Pediatr Nephrol. 2015 Jun;30(6):999-1005. doi: 10.1007/s00467-014-3005-2. Epub 2014 Nov 15.
6
Non invasive evaluation of cardiac hemodynamics in end stage renal disease (ESRD).终末期肾病(ESRD)中心脏血流动力学的无创评估。
High Blood Press Cardiovasc Prev. 2014 Dec;21(4):261-8. doi: 10.1007/s40292-014-0045-4. Epub 2014 Feb 19.
7
N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?N 端脑利钠肽前体——血液透析患者心功能障碍、液体超负荷或营养不良的标志物?
Clin J Am Soc Nephrol. 2010 Jun;5(6):1036-40. doi: 10.2215/CJN.09001209. Epub 2010 May 27.